Aspen Pharmacare Manufacturing Dispute Shrouded in Mystery

Original Article by Kabelo Khumalo | Business Day | 23 April 2025

Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.

Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Momentum Group Posts Record Earnings

Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.

Read more...

Sanlam Writes Down AfroCentric to Nil but Won’t Sell

Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.

Read more...

GLP-1 Alone Won’t Solve South Africa’s Diabetes Crisis

GLP-1 medicines alone can’t solve SA’s diabetes crisis, experts warn, urging earlier screening, coordinated care and better food access.

Read more...